Compare Hershey Co (HSY) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hershey Co vs Tilray Brands Inc — how do they compare? Hershey Co trades at $162.74 (market cap $32.66B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Hershey Co is far larger — about 61.6× Tilray Brands Inc's market cap, and Hershey Co pays a 3.57% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hershey Co for 135 Days and Tilray Brands Inc for 31 Days on average.
| HSY | TLRY | |
|---|---|---|
Market Cap | $32.66B | $530.54M |
Volume | 1,578,237 | 9,099,075 |
Sector | Consumer Staples | Health |
52-Week High | $236.28 | $17.20 |
52-Week Low | $157.61 | $3.54 |
Typical Hold Time | 135 Days | 31 Days |
Enterprise Value | $37.79B | $684.46M |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hershey (HSY) trades at $162.54, up 1.37% with a bearish technical signal despite beating earnings expectations for three consecutive quarters. The stock shows strong profitability with 12.24% net margin and 32.81% ROE, though 2025 net income declined significantly. Recent news highlights dividend resumption and international leadership changes while analysts maintain a cautious stance with 65.72% hold ratings.
HSY presents a mixed outlook with solid fundamentals offset by near-term challenges. The 26% upside to consensus price target of $204.62 offers potential, but cocoa cost pressures and technical bearishness warrant caution. Dividend investors may find value given the recent payout resumption, though margin compression remains a key monitorable.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
